13-Apr-2016 - GE Healthcare UK Ltd.

GE Healthcare expands European capabilities to support accelerated biomanufacturing

Rapid Response Production service for research, process development, and bioproduction launched

GE Healthcare’s Life Sciences business announced that its European manufacturing and distribution site for sterile liquids has expanded its capabilities to include production of large volumes of buffers, process liquids and cell culture media, and launched a rapid production service for prototype cell culture media and buffers. The site in Pasching, Austria, mirrors the high quality and performance standards of the business’ Center of Excellence in Logan, Utah, meeting customers’ requirements for consistent global quality management.

Biopharmaceuticals and vaccines are used in the treatment of cancer, autoimmune disorders and other areas of unmet medical need. Manufacturing of these biopharmaceuticals requires a reliable, flexible supply of a range of sterile liquids, including cell culture media and buffers, to support high-yield production and efficient purification of the target product. The Pasching facility serves biopharmaceutical companies in over 40 countries across Europe, Africa and the Middle East.

Development and scale-up of bioprocesses frequently require quick manufacture of prototype media and buffers to facilitate timely process evaluation and fast implementation. GE’s Pasching site now also offers Rapid Response Production services, enabling production of small volumes of prototype cell culture media and buffers within five days of ordering. The use of consistent and replicable manufacturing practices supports efficient future transfer to cGMP production for biomanufacturers.

David Radspinner, PhD, General Manager of Bioprocess Cell Culture at GE Healthcare’s Life Sciences business, said: “Our aim is to accelerate development and scale-up for our biomanufacturing customers by providing simplified, flexible services both in Europe and in other regions. The capabilities of our Pasching facility will enable us to seamlessly support our customers globally, ensuring security of supply with multiple manufacturing sites that are qualified and validated to the same quality standards.”

GE’s additional production capacity at Pasching has been developed over two years, with an investment of $4.3m USD (€3.8m). The site is also a production and distribution centre for Europe, with more than 300,000 individual product items shipped through the site per year.

Facts, background information, dossiers
  • GE Healthcare
More about GE Healthcare
  • News

    GE Healthcare and Takeda Join Forces to Develop Therapeutic Drugs to Target Liver Diseases

    GE Healthcare and Takeda Pharmaceutical Company announced that they have entered into an alliance agreement for research and development in the field of hepatic fibrosis, a key factor in the diagnosis and treatment of liver diseases. Liver disease has almost no visible symptoms, and its pr ... more

    VTT and GE Healthcare developing novel biomarkers to predict Alzheimer’s disease

    Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer’s disease months or even years before the first symptoms of the disease occur. The ... more

    GE Healthcare Life Sciences completes acquisition of Xcellerex, Inc.

    GE Healthcare announced that it has completed the acquisition of Xcellerex, Inc., a supplier of manufacturing technologies for the fast-growing biopharmaceutical industry. The acquisition expands GE Healthcare’s offering of technologies and services for the manufacture of biopharmaceuticals ... more

  • Videos

    New Generation SEC Columns for Small-Scale Preparative Purification and Analysis of Proteins

    The new generation size exclusion chromatography columns called “Increase” from GE Healthcare offer improved performance than their predecessors.  Comprising smaller, more rigid beads with a narrower particle size distribution and a higher selectivity than their predecessors, they offer: R ... more

    ÄKTA Protein Purification Systems – Easy to Use Benchtop Systems to Accelerate Daily Routines

    ÄKTA™ lab-scale protein purification systems are designed for purification of biomolecules, providing speed, performance, and flexibility in research and process development. ÄKTA systems use intelligent UNICORN™ system control software to combine simplicity with power in protein purificati ... more

    Protein Purification Handbooks

    GE Healthcare’s Life Sciences business offers principles and methodology handbooks covering a wide range of techniques and applications including sample preparation, protein purification, electrophoresis, blotting, and cell culture. Whether you’re a beginner or an expert, our handbooks are ... more

  • Companies

    GE Healthcare

    GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutica ... more

    GE Healthcare AB

    GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutica ... more